| Date | Time | Source | Headline | Symbol | Company |
| 14/02/2014 | 16:35 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 17/10/2013 | 00:35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 17/10/2013 | 00:35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 17/10/2013 | 00:34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 17/10/2013 | 00:34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 17/10/2013 | 00:34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 17/10/2013 | 00:33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 17/10/2013 | 00:33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 17/10/2013 | 00:32 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 17/10/2013 | 00:32 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 17/10/2013 | 00:31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 17/10/2013 | 00:31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 17/10/2013 | 00:31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 14/10/2013 | 21:30 | GlobeNewswire Inc. | Astex Pharmaceuticals to Present at AACR-NCI-EORTC | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 11/10/2013 | 19:05 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 11/10/2013 | 19:05 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 11/10/2013 | 19:04 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 11/10/2013 | 19:04 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 11/10/2013 | 19:03 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 11/10/2013 | 19:03 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 11/10/2013 | 14:17 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 11/10/2013 | 13:37 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 11/10/2013 | 13:30 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 11/10/2013 | 13:23 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 10/10/2013 | 11:03 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 10/10/2013 | 03:37 | GlobeNewswire Inc. | Astex Pharmaceuticals Responds to Further Misleading Claims Made by Sarissa Capital | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 09/10/2013 | 22:27 | PR Newswire (US) | Sarissa Capital Highlights Advancement Of Astex Pipeline Compound | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 09/10/2013 | 21:53 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 09/10/2013 | 21:49 | PR Newswire (US) | Sarissa Capital Highlights Advancement Ofastex Pipeline Compound | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 08/10/2013 | 21:19 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |